Showing results (301-310 of 350) with videos related to

Sort By:
Pageof 35
Diabetic Medicine : a Journal of the British Diabetic Association|September 22, 2010
Fear of hypoglycaemia in adults with Type 1 diabetesT Anderbro, S Amsberg, U Adamson, et al.
International Journal of Obesity (2005)|November 30, 2006
Association of a beta-2 adrenoceptor (ADRB2) gene variant with a blunted in vivo lipolysis and fat oxidationJ W E Jocken, E E Blaak, S Schiffelers, et al.
Diabetologia|April 1, 1991
Screening for insulin receptor gene DNA polymorphisms associated with glucose intolerance in a Scandinavian populationM Sten-Linder, S Vilhelmsdotter, A Wedell, et al.
Thrombosis and Haemostasis|April 26, 2000
Regional variation in plasminogen activator inhibitor-1 expression in adipose tissue from obese individualsP Eriksson, V Van Harmelen, J Hoffstedt, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|February 11, 2009
Primary differences in lipolysis between human omental and subcutaneous adipose tissue observed using in vitro differentiated adipocytesA Dicker, G Aström, K Wåhlén, et al.
Lancet (London, England)|November 19, 1994
Transplantation of porcine fetal pancreas to diabetic patientsC G Groth, O Korsgren, A Tibell, et al.
Diabetes/Metabolism Research and Reviews|July 22, 2014
The risk for diabetic nephropathy is low in young adults in a 17-year follow-up from the Diabetes Incidence Study in Sweden (DISS). Older age and higher BMI at diabetes onset can be important risk factorsM K Svensson, M Tyrberg, L Nyström, et al.
Diabetologia|July 11, 2002
The incidence of Type I diabetes has not increased but shifted to a younger age at diagnosis in the 0-34 years group in Sweden 1983-1998A Pundziute-Lyckå, G Dahlquist, L Nyström, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|November 8, 2005
Hyperproinsulinemia segregates young adult patients with newly diagnosed autoimmune (type 1) and non-autoimmune (type 2) diabetesJ Bolinder, P Fernlund, H Borg, et al.
Diabetologia|February 24, 2007
Atrial natriuretic peptide inhibits the production of adipokines and cytokines linked to inflammation and insulin resistance in human subcutaneous adipose tissueC Moro, E Klimcakova, K Lolmède, et al.
Pageof 35